18 participants
A Phase I/II Study of JL19001 Injection Alone or in Combination With BCG in Subjects With High Risk Non-Muscle Invasive Bladder Cancer.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-06
- Start Date:
- 2026-05-18
- Completion:
- 2027-03-30
Conditions
- High Risk Non-muscle Invasive Bladder Cancer
Interventions
- DRUG
No Results Yet